These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 38666971)

  • 1. The Importance of Carbapenemase-Producing Enterobacterales in African Countries: Evolution and Current Burden.
    Chelaru EC; Muntean AA; Hogea MO; Muntean MM; Popa MI; Popa GL
    Antibiotics (Basel); 2024 Mar; 13(4):. PubMed ID: 38666971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance Among Enterobacterales and Other Gram-Negative Bacteria.
    Hansen GT
    Infect Dis Ther; 2021 Mar; 10(1):75-92. PubMed ID: 33492641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating NG-Test CARBA 5 Multiplex Immunochromatographic and Cepheid Xpert CARBA-R Assays among Carbapenem-Resistant
    Huang YT; Kuo YW; Lee NY; Tien N; Liao CH; Teng LJ; Ko WC; Hsueh PR;
    Microbiol Spectr; 2022 Feb; 10(1):e0172821. PubMed ID: 35019772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.
    Hagihara M; Kato H; Sugano T; Okade H; Sato N; Shibata Y; Sakanashi D; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Mikamo H
    Int J Antimicrob Agents; 2021 May; 57(5):106330. PubMed ID: 33789129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Hospital Outbreaks of New Delhi Metallo-β-Lactamase-Producing
    Lo S; Lolom I; Goldstein V; Petitjean M; Rondinaud E; Bunel-Gourdy V; Tran Dinh A; Wicky PH; Ruppé E; d'Humières C; Lucet JC; Armand-Lefèvre L
    Microbiol Spectr; 2022 Apr; 10(2):e0228721. PubMed ID: 35311539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenem resistance in
    Ramkisson T; Rip D
    AIMS Microbiol; 2023; 9(4):668-691. PubMed ID: 38173973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal Carriage and Molecular Characterization of Carbapenemase-Producing
    Pérez-López A; Sundararaju S; Tsui KM; Al-Mana H; Hasan MR; Suleiman M; Al Maslamani E; Imam O; Roscoe D; Tang P
    Microbiol Spectr; 2021 Dec; 9(3):e0112221. PubMed ID: 34756089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors and Outcomes of Patients Colonized with KPC and NDM Carbapenemase-Producing Enterobacterales.
    Saidel-Odes L; Sagi O; Troib S; Leeman H; Nativ R; Schlaeffer-Yosef T; Azulay H; Nesher L; Borer A
    Antibiotics (Basel); 2024 May; 13(5):. PubMed ID: 38786155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early OXA-48-Producing
    Gijón D; Tedim AP; Valverde A; Rodríguez I; Morosini MI; Coque TM; Manrique M; Pareja E; Tobes R; Ruiz-Garbajosa P; Cantón R
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Report of OXA-181-Producing
    Cuicapuza D; Alvarado L; Tocasca N; Aguilar D; Gómez-de-la-Torre JC; Salvatierra G; Tsukayama P; Tamariz J
    Microbiol Spectr; 2023 Jun; 11(3):e0458422. PubMed ID: 37022279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of carbapenemase-producing Enterobacterales in a tertiary hospital in Lima, Peru.
    Cuicapuza D; Loyola S; Velásquez J; Fernández N; Llanos C; Ruiz J; Tsukayama P; Tamariz J
    Microbiol Spectr; 2024 Feb; 12(2):e0250323. PubMed ID: 38193666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology of clinical isolation of carbapenem-resistant Enterobacterales and application of carbapenemase inhibitor enhancement test.
    Li H; Zhong Y; Yan Q; Liu W; Liang X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1210-1216. PubMed ID: 37875361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CARBA-MAP study: national mapping of carbapenemases in Spain (2014-2018).
    Gracia-Ahufinger I; López-González L; Vasallo FJ; Galar A; Siller M; Pitart C; Bloise I; Torrecillas M; Gijón-Cordero D; Viñado B; Castillo-García J; Campo R; Mulet X; Madueño-Alonso A; Chamizo-López FJ; Arrastia-Erviti M; Galán-Sánchez F; Fernández-Quejo M; Rodríguez-Díaz JC; Gutiérrez-Zufiaurre MN; Rodríguez-Maresca MA; Ortega-Lafont MDP; Yagüe-Guirao G; Chaves-Blanco L; Colomina-Rodríguez J; Vidal-Acuña MR; Portillo ME; Franco-Álvarez de Luna F; Centelles-Serrano MJ; Azcona-Gutiérrez JM; Delgado-Iribarren García Campero A; Rey-Cao S; Muñoz P; Calvo-Montes J; Zboromyrska Y; Grandioso D; Càmara J; Cantón R; Larrosa-Escartín N; Díaz-Regañón J; Martínez-Martínez L
    Front Microbiol; 2023; 14():1247804. PubMed ID: 37744921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Study of Carbapenemase-Producing
    Yu H; González Molina MK; Carmona Cartaya Y; Hart Casares M; Aung MS; Kobayashi N; Quiñones Pérez D
    Antibiotics (Basel); 2022 Apr; 11(4):. PubMed ID: 35453265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017-2019.
    Wielders CCH; Schouls LM; Woudt SHS; Notermans DW; Hendrickx APA; Bakker J; Kuijper EJ; Schoffelen AF; de Greeff SC; ;
    Antimicrob Resist Infect Control; 2022 Apr; 11(1):57. PubMed ID: 35397546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Longitudinal Nine-Year Study of the Molecular Epidemiology of Carbapenemase-Producing
    Duong TTT; Tsai YM; Wen LL; Chiu HC; Chen PK; Thuy TTD; Kuo PY; Hidrosollo JH; Wang S; Zhang YZ; Lin WH; Wang MC; Kao CY
    Front Microbiol; 2022; 13():703113. PubMed ID: 35359715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.
    Marimuthu K; Ng OT; Cherng BPZ; Fong RKC; Pada SK; De PP; Ooi ST; Smitasin N; Thoon KC; Krishnan PU; Ang MLT; Chan DSG; Kwa ALH; Deepak RN; Chan YK; Chan YFZ; Huan X; Zaw Linn K; Tee NWS; Tan TY; Koh TH; Lin RTP; Hsu LY; Sengupta S; Paterson DL; Perencevich E; Harbarth S; Teo J; Venkatachalam I;
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-Year Survey of Asymptomatic Colonization with Multidrug-Resistant Organisms in a Romanian Tertiary Care Hospital.
    Tălăpan D; Rafila A
    Infect Drug Resist; 2022; 15():2959-2967. PubMed ID: 35706926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant
    Shortridge D; Kantro V; Castanheira M
    Microbiol Spectr; 2023 Feb; 11(1):e0450722. PubMed ID: 36622238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
    Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
    Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.